Leadership Overview
MMS Holdings has 5 executives leading key functions including strategy, financial oversight, operational execution, and corporate leadership.
Focused on advancing global clinical research through data-driven innovation, MMS Holdings delivers technology-enabled solutions that accelerate drug development and ensure regulatory compliance for pharmaceutical and biotech partners worldwide.
Focused on advancing global clinical research through data-driven innovation, MMS Holdings delivers technology-enabled solutions that accelerate drug development and ensure regulatory compliance for pharmaceutical and biotech partners worldwide.
Leadership Roles at MMS Holdings
Uma Sharma - Chief Executive Officer
Uma Sharma, the Chief Executive Officer at MMS Holdings, directs the overarching strategic vision for this global data-focused clinical research organization. Sharma architects long-term growth initiatives while overseeing the integration of advanced AI and health data analytics across all service lines. By aligning corporate objectives with the evolving needs of the pharmaceutical and medical device industries, the Chief Executive Officer ensures consistent delivery of high-quality regulatory submissions and biometrics solutions. This leadership role involves fostering a culture of innovation that drives efficiency in drug development processes across North American and international markets. Uma Sharma maintains close collaboration with the board to secure market leadership and client satisfaction. Through rigorous oversight of organizational performance, the Chief Executive Officer sustains the company's reputation for excellence in complex clinical trial execution and strategic consulting, ultimately positioning the firm as a premier partner for global life sciences organizations.
Stacy Rusley - Chief Financial Officer
Stacy Rusley, the Chief Financial Officer at MMS Holdings, manages the fiscal health and capital allocation strategies for this technology-enabled clinical research organization. Rusley oversees financial planning, reporting, and risk management frameworks that support the company's global expansion and investment in AI-driven research tools. By optimizing resource distribution across biometrics and regulatory submission departments, the Chief Financial Officer ensures the firm maintains a competitive edge in the pharmaceutical services market. This role involves direct engagement with executive leadership to evaluate the financial viability of new service offerings and international market entries. Stacy Rusley drives fiscal discipline while supporting the infrastructure necessary for high-volume clinical data analytics. Through precise financial modeling and performance analysis, the Chief Financial Officer secures the stability required for long-term growth, enabling the organization to meet the rigorous demands of the biotech and medical device sectors with consistent operational excellence.
Abdul Ch - Chief Operating Officer
Abdul Ch, the Chief Operating Officer at MMS Holdings, directs the internal operational workflows and service delivery mechanisms for this global clinical research organization. Ch focuses on scaling the company's biometrics and safety management capabilities to ensure seamless execution of complex clinical trials. By refining operational processes and integrating advanced technology platforms, the Chief Operating Officer enhances the efficiency of regulatory submissions for pharmaceutical and medical device clients. This leadership role involves managing cross-functional teams to maintain high standards of compliance and data integrity across all global projects. Abdul Ch monitors operational metrics to identify opportunities for process improvement and capacity expansion in key regional markets. Through the implementation of standardized operational protocols, the Chief Operating Officer supports the firm's commitment to innovation, ensuring that every clinical research project benefits from optimized workflows and superior data analytics, ultimately driving successful outcomes for the company's diverse client base.
Micky Miranda - President
Micky Miranda, the President at MMS Holdings, leads the strategic development and execution of specialized clinical research services for the pharmaceutical and biotech industries. Miranda oversees the expansion of the company's regulatory submission and strategic consulting divisions, ensuring alignment with global industry standards. By fostering strong client relationships and identifying emerging market opportunities, the President drives the adoption of innovative health data analytics solutions. This role involves coordinating with other executive leaders to refine service delivery models that address the unique challenges of drug development and medical device testing. Micky Miranda manages the growth of regional operations, ensuring that the firm maintains its reputation for excellence in complex, data-intensive environments. Through proactive leadership and a focus on client-centric service, the President strengthens the company's market position, facilitating the successful delivery of critical research projects that advance medical science and improve patient outcomes on a global scale.
Yonghoon Jeong - President
Yonghoon Jeong, the President at MMS Holdings, directs the technical integration and innovation strategy for the company's clinical research and health data analytics solutions. Jeong focuses on the application of advanced AI and machine learning to enhance trial design and execution, ensuring that the firm remains at the forefront of the CRO industry. By overseeing the development of proprietary technology platforms, the President supports the biometrics and safety management teams in delivering high-precision results for pharmaceutical and medical device clients. This leadership role involves driving digital transformation initiatives that streamline regulatory processes and improve data accuracy. Yonghoon Jeong collaborates with global teams to implement scalable technology solutions that meet the evolving needs of the life sciences sector. Through the continuous refinement of technical capabilities, the President ensures that the organization maintains its competitive advantage, providing clients with the sophisticated tools necessary for efficient, compliant, and successful drug development programs.
Explore Leadership Teams in Business Services
Founded in 1965, based in Rockville, Maryland, Abt Global is an engine for social impact, fueled by caring, curiosity and cutting-edge research that moves people from vulnerability to security. Whether it's welfare or weather disasters, the environment or economics, agriculture or HIV and AIDS, we address the world's most pressing issues.
Company Leadership MK
KF
BP

The RNA Institute is a collaborative research facility that unites leading researchers from academia and industry to advance RNA research critical for human health. It offers advanced instrumentation and training programs aimed at developing the next generation of RNA scientists, with a focus on inclusivity and diversity in STEM. The Institute is dedicated to creating tools and analytics for RNA-based therapeutics and diagnostics, while fostering interdisciplinary research across various scientific fields. Its unique opportunities for collaboration and comprehensive training programs cater to researchers and trainees at all levels, from high school to post-doctoral studies.
Company Leadership JN
GB
MS
CH
MISTRAS Group, Inc. is a global industrial services and technology company specializing in asset integrity, non-destructive testing, inspection, condition monitoring, engineering, laboratory testing, and data-driven asset protection solutions. Headquartered in Princeton Junction, New Jersey, the company serves organizations that operate critical industrial and infrastructure assets where safety, reliability, regulatory compliance, operational continuity, and asset life are important business requirements. MISTRAS combines technical inspection expertise, engineering capabilities, laboratory testing, field services, monitoring technologies, proprietary software, and data analytics to help customers identify defects,
Company Leadership



Microbac Laboratories is a provider of laboratory testing for environmental, food and life sciences. Microbac was founded in 1969 and is currently headquartered in Pittsburgh, PA
Company Leadership CL

RA
DF